are now a part of the new and improved


Topic: Skin Cancer

News | March 21, 2019

Biofrontera Reports Positive Phase 3 Results with Ameluz for PDT of AKs on Extremities and Trunk/Neck

Results for the primary endpoint of Biofrontera AG's Phase 3 clinical trial evaluating the safety and efficacy of conventional photodynamic therapy (PDT) with Ameluz and the BF-RhodoLED lamp for the treatment of actinic keratoses (AK)...

Read More

News | March 1, 2019

Arkansas Gets SUNucated

Arkansas has joined 18 other states in adopting legislation to allow children to possess and apply sunscreen at school. Governor Asa Hutchinson signed into law HB 1167, which was co-sponsored by Representative Lee Johnson, MD, and...

Read More

News | March 15, 2019

Constellation Alpha Capital Corp. Signs Letter of Intent to Acquire DermTech, Inc.

Constellation Alpha Capital Corp., a special purpose acquisition company, has executed a non-binding Letter of Intent to merge with DermTech, Inc., a molecular genomics company with an initial focus on skin cancer. DermTech markets and...

Read More
Resident Resource Center | March 2019

Subcutaneous Sarcoidosis Diagnosed in a 55-Year-Old Female

Gabrielle Kartzmark, BS; Victoria R. Negrete, MD; and John Pujals, MD

Subcutaneous sarcoidosis (also known as ‘Darier-Roussy sarcoidosis’) is a rare subcutaneous form of sarcoidosis, occurring in 1.4 to six percent of patients with sarcoidosis. It is characterized by firm, asymptomatic to slightly...

Read Article


The Latest in Skin Cancer


View more